Conference Roundup

Presentation talks prevalence of hearing-related issues in TED patients treated with teprotumumab

There is a lack of independent data on the prevalence of hearing-related issues in thyroid eye disease (TED) patients and those receiving teprotumumab. To estimate the background rates of hearing-related changes, a study was conducted using deidentified closed claims data from the KOMODO database, cohorts of patients with Graves’ disease...